Bambusa Therapeutics, Inc. (BBTX)
Nasdaq: BBTX · CIK 0002044950 · United States
Every official Bambusa Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BBTX filings
Bambusa Therapeutics, Inc. documents
- Bambusa Therapeutics, Inc. 10-K 2026BBTX 10-K 2026: annual report for fiscal 2026
- Bambusa Therapeutics, Inc. 10-K 2025BBTX 10-K 2025: annual report for fiscal 2025
- Bambusa Therapeutics, Inc. 10-K 2024BBTX 10-K 2024: annual report for fiscal 2024
- Bambusa Therapeutics, Inc. 10-K 2023BBTX 10-K 2023: annual report for fiscal 2023
- Bambusa Therapeutics, Inc. 10-K 2022BBTX 10-K 2022: annual report for fiscal 2022
- Bambusa Therapeutics, Inc. 10-Q 2026BBTX 10-Q 2026: quarterly report for fiscal 2026
- Bambusa Therapeutics, Inc. 10-Q 2025BBTX 10-Q 2025: quarterly report for fiscal 2025
- Bambusa Therapeutics, Inc. 10-Q 2024BBTX 10-Q 2024: quarterly report for fiscal 2024
- Bambusa Therapeutics, Inc. 10-Q 2023BBTX 10-Q 2023: quarterly report for fiscal 2023
- Bambusa Therapeutics, Inc. 10-Q 2022BBTX 10-Q 2022: quarterly report for fiscal 2022
- Bambusa Therapeutics, Inc. 8-K 2026BBTX 8-K 2026: current report for fiscal 2026
- Bambusa Therapeutics, Inc. 8-K 2025BBTX 8-K 2025: current report for fiscal 2025
- Bambusa Therapeutics, Inc. 8-K 2024BBTX 8-K 2024: current report for fiscal 2024
- Bambusa Therapeutics, Inc. 8-K 2023BBTX 8-K 2023: current report for fiscal 2023
- Bambusa Therapeutics, Inc. 8-K 2022BBTX 8-K 2022: current report for fiscal 2022
- Bambusa Therapeutics, Inc. DEF 14A 2026BBTX DEF 14A 2026: proxy statement for fiscal 2026
- Bambusa Therapeutics, Inc. DEF 14A 2025BBTX DEF 14A 2025: proxy statement for fiscal 2025
- Bambusa Therapeutics, Inc. DEF 14A 2024BBTX DEF 14A 2024: proxy statement for fiscal 2024
- Bambusa Therapeutics, Inc. DEF 14A 2023BBTX DEF 14A 2023: proxy statement for fiscal 2023
- Bambusa Therapeutics, Inc. DEF 14A 2022BBTX DEF 14A 2022: proxy statement for fiscal 2022
- Bambusa Therapeutics, Inc. Form 4 2026BBTX Form 4 2026: insider trading filing for fiscal 2026
- Bambusa Therapeutics, Inc. Form 4 2025BBTX Form 4 2025: insider trading filing for fiscal 2025
- Bambusa Therapeutics, Inc. Form 4 2024BBTX Form 4 2024: insider trading filing for fiscal 2024
- Bambusa Therapeutics, Inc. Form 4 2023BBTX Form 4 2023: insider trading filing for fiscal 2023
- Bambusa Therapeutics, Inc. Form 4 2022BBTX Form 4 2022: insider trading filing for fiscal 2022
- Bambusa Therapeutics, Inc. S-1 2026BBTX S-1 2026: registration statement for fiscal 2026
- Bambusa Therapeutics, Inc. S-1 2025BBTX S-1 2025: registration statement for fiscal 2025
- Bambusa Therapeutics, Inc. S-1 2024BBTX S-1 2024: registration statement for fiscal 2024
- Bambusa Therapeutics, Inc. S-1 2023BBTX S-1 2023: registration statement for fiscal 2023
- Bambusa Therapeutics, Inc. S-1 2022BBTX S-1 2022: registration statement for fiscal 2022
- Bambusa Therapeutics, Inc. 13F 2026BBTX 13F 2026: institutional holdings for fiscal 2026
- Bambusa Therapeutics, Inc. 13F 2025BBTX 13F 2025: institutional holdings for fiscal 2025
- Bambusa Therapeutics, Inc. 13F 2024BBTX 13F 2024: institutional holdings for fiscal 2024
- Bambusa Therapeutics, Inc. 13F 2023BBTX 13F 2023: institutional holdings for fiscal 2023
- Bambusa Therapeutics, Inc. 13F 2022BBTX 13F 2022: institutional holdings for fiscal 2022
More companies